MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    Basal forebrain contribution to cognitive deficits during medication “off” state in Parkinson’s disease

    D. Lench, T. Turner, E. Woolbright, F. Rodriguez-Porcel, G. Revuelta (Charleston, USA)

    Objective: We sought to determine whether structural integrity of cholinergic Basal Forebrain (BF) was associated with subjective cognitive deficits experienced during medication “off” time Parkinson’s…
  • 2022 International Congress

    Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease

    D. Weintraub, M. Picillo, H. Cho, C. Caspell-Garcia, C. Coffey, K. Marek, K. Poston, T. Simuni, J. Seibyl, A. Siderowf, A. Singleton, C. Tanner (Philadelphia, USA)

    Objective: To determine the impact of the dopamine system (dopamine transporter [DAT] availability, dopamine-related SNPs, and dopaminergic medication use) on long-term cognitive performance in early…
  • 2022 International Congress

    Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

    S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)

    Objective: The aim of this study is to evaluate the priming effect of visual, auditory and cognitive tasks in enhancing Motor Imagery (MI) ability in…
  • 2022 International Congress

    Huntington’s Disease, Cognition, and Fear of Falling

    A. Sethi, S. Baek, O. Kaczmarek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship of cognition and patient-reported assessment on fear of falling in people with Huntington’s Disease. Background: Huntington’s Disease (HD) is a relentlessly…
  • 2022 International Congress

    Longitudinal predictors of functional dependence in a multicentric Parkinson’s Disease cohort

    S. Becker, B. Callahan (Calgary, Canada)

    Objective: To explore clinical and cognitive predictors of functional dependence in a cohort of early Parkinson’s Disease (PD) patients. Background: Parkinson’s Disease (PD) patients are…
  • 2022 International Congress

    A Useful Cognitive-Motor Dual Task Paradigm in Prodromal and Manifest HD

    EG. Churchill, J. Corey-Bloom, A. Hall, C. Snell, A. Smirnova, SB. Hughes, PE. Gilbert, DJ. Goble (San Diego, USA)

    Objective: To investigate whether a cognitive-motor dual task (DT) paradigm uncovers deficits in balance in Huntington’s disease (HD) and, more importantly, prodromal HD, compared to…
  • 2022 International Congress

    Late Onset Ataxia, Myoclonus, and Cognitive Decline in a Patient with Xeroderma Pigmentosum: A Case Report

    J. Modica, A. Hewitt, P. Morrison (Rochester, USA)

    Objective: To present a case of late onset neurologic symptoms of ataxia, myoclonus, and cognitive impairment in a 37-year-old man with xeroderma pigmentosum (XP). Background:…
  • 2022 International Congress

    Influence of alcohol consumption on cognitive decline in Parkinson disease.

    E. Ruiz-Fernández, J. Marín-Lahoz, J. Pagonabarraga, A. Horta-Barba, S. Martínez-Horta, H. Bejr-Kasem, I. Aracil-Bolaños, A. Campolongo, J. Kulisevsky (Zaragoza, Spain)

    Objective: To assess whether alcohol consumption (AC) is independently associated with cognitive decline (CD) in PD. Background: AC is linked to dementia and neurological damage…
  • 2022 International Congress

    Robust methods for missing covariates in longitudinal studies with application to biomarker research in Parkinson’s disease dementia

    L. Suttner, P. Zhang, S. Xie (Philadelphia, USA)

    Objective: We propose a nonparametric method for handling different types of missing covariates in longitudinal studies. We show that the proposed method outperforms multiple standard…
  • 2022 International Congress

    A randomized clinical trial (RCT) to evaluate the effects of safinamide on apathetic non-demented Parkinson’s disease patients

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, I. Aracil-Bolaños, J. Rodriguez-Antiguedad (Barcelona, Spain)

    Objective: To evaluate the safety and effects of add-on safinamide on apathy in patients with Parkinson’s disease (PD). Background: Apathy is highly prevalent and disabling…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Clinical Associations of Hand Deformities in Parkinson´s Disease
  • #24970 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley